These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 19020748)

  • 1. Annexin A2 expression and phosphorylation are up-regulated in hepatocellular carcinoma.
    Mohammad HS; Kurokohchi K; Yoneyama H; Tokuda M; Morishita A; Jian G; Shi L; Murota M; Tani J; Kato K; Miyoshi H; Deguchi A; Himoto T; Usuki H; Wakabayashi H; Izuishi K; Suzuki Y; Iwama H; Deguchi K; Uchida N; Sabet EA; Arafa UA; Hassan AT; El-Sayed AA; Masaki T
    Int J Oncol; 2008 Dec; 33(6):1157-63. PubMed ID: 19020748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced expression of the protein kinase substrate annexin in human hepatocellular carcinoma.
    Masaki T; Tokuda M; Ohnishi M; Watanabe S; Fujimura T; Miyamoto K; Itano T; Matsui H; Arima K; Shirai M; Maeba T; Sogawa K; Konishi R; Taniguchi K; Hatanaka Y; Hatase O; Nishioka M
    Hepatology; 1996 Jul; 24(1):72-81. PubMed ID: 8707286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.
    Masaki T; Tokuda M; Yoshida S; Nakai S; Morishita A; Uchida N; Funaki T; Kita Y; Funakoshi F; Nonomura T; Himoto T; Deguchi A; Kimura Y; Izuishi K; Wakabayashi H; Usuki H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
    Int J Oncol; 2005 Mar; 26(3):661-71. PubMed ID: 15703821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Annexin A2 as a differential diagnostic marker of hepatocellular tumors.
    Longerich T; Haller MT; Mogler C; Aulmann S; Lohmann V; Schirmacher P; Brand K
    Pathol Res Pract; 2011 Jan; 207(1):8-14. PubMed ID: 20971570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].
    Tátrai P
    Magy Onkol; 2008 Dec; 52(4):379-83. PubMed ID: 19068466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of c-Yes expression in the nuclei of hepatocellular carcinoma cells: involvement in the early stages of hepatocarcinogenesis.
    Nonomura T; Masaki T; Morishita A; Jian G; Uchida N; Himoto T; Izuishi K; Iwama H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
    Int J Oncol; 2007 Jan; 30(1):105-11. PubMed ID: 17143518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of matrix metalloproteinase 9 gene in hepatocellular carcinoma with invasive potential.
    Arii S; Mise M; Harada T; Furutani M; Ishigami S; Niwano M; Mizumoto M; Fukumoto M; Imamura M
    Hepatology; 1996 Aug; 24(2):316-22. PubMed ID: 8690399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression characteristics and diagnostic value of annexin A2 in hepatocellular carcinoma.
    Zhang HJ; Yao DF; Yao M; Huang H; Wu W; Yan MJ; Yan XD; Chen J
    World J Gastroenterol; 2012 Nov; 18(41):5897-904. PubMed ID: 23139605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of alpha-fetoprotein and albumin genes in human hepatocellular carcinomas: limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy.
    Ohguchi S; Nakatsukasa H; Higashi T; Ashida K; Nouso K; Ishizaki M; Hino N; Kobayashi Y; Uematsu S; Tsuji T
    Hepatology; 1998 Feb; 27(2):599-607. PubMed ID: 9462663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteonectin/SPARC is overexpressed in human hepatocellular carcinoma.
    Le Bail B; Faouzi S; Boussarie L; Guirouilh J; Blanc JF; Carles J; Bioulac-Sage P; Balabaud C; Rosenbaum J
    J Pathol; 1999 Sep; 189(1):46-52. PubMed ID: 10451487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
    Chuma M; Hige S; Nakanishi M; Ogawa K; Natsuizaka M; Yamamoto Y; Asaka M
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1431-6. PubMed ID: 18854000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of RhoA in progression of human hepatocellular carcinoma.
    Wang D; Dou K; Xiang H; Song Z; Zhao Q; Chen Y; Li Y
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1916-20. PubMed ID: 17914970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo expression patterns of survivin and its splicing variants in chronic liver disease and hepatocellular carcinoma.
    Takashima H; Nakajima T; Moriguchi M; Sekoguchi S; Nishikawa T; Watanabe T; Katagishi T; Kimura H; Minami M; Itoh Y; Kagawa K; Okanoue T
    Liver Int; 2005 Feb; 25(1):77-84. PubMed ID: 15698402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of iron-regulatory genes in human hepatocellular carcinoma and its physiological consequences.
    Tan MG; Kumarasinghe MP; Wang SM; Ooi LL; Aw SE; Hui KM
    Exp Biol Med (Maywood); 2009 Jun; 234(6):693-702. PubMed ID: 19307463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and analysis of altered alpha1,6-fucosylated glycoproteins associated with hepatocellular carcinoma metastasis.
    Dai Z; Liu YK; Cui JF; Shen HL; Chen J; Sun RX; Zhang Y; Zhou XW; Yang PY; Tang ZY
    Proteomics; 2006 Nov; 6(21):5857-67. PubMed ID: 17068759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of vanilloid receptor-1 is associated with better prognosis of patients with hepatocellular carcinoma.
    Miao X; Liu G; Xu X; Xie C; Sun F; Yang Y; Zhang T; Hua S; Fan W; Li Q; Huang S; Wang Q; Liu G; Zhong D
    Cancer Genet Cytogenet; 2008 Oct; 186(1):25-32. PubMed ID: 18786439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of the fragile histidine triad gene in hepatitis C virus-associated hepatocellular carcinoma.
    Zekri AR; Bahnassy AA; Hafez M; El-Shehaby AM; Sherif GM; Khaled HM; Zakhary N
    J Gastroenterol Hepatol; 2005 Jan; 20(1):87-94. PubMed ID: 15610452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced expression of S8, L12, L23a, L27 and L30 ribosomal protein mRNAs in human hepatocellular carcinoma.
    Kondoh N; Shuda M; Tanaka K; Wakatsuki T; Hada A; Yamamoto M
    Anticancer Res; 2001; 21(4A):2429-33. PubMed ID: 11724303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of annexin A2 expression predicates advanced clinicopathological features and poor prognosis in hepatocellular carcinoma.
    Zhang H; Yao M; Wu W; Qiu L; Sai W; Yang J; Zheng W; Huang J; Yao D
    Tumour Biol; 2015 Dec; 36(12):9373-83. PubMed ID: 26109000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags.
    Yoon SY; Kim JM; Oh JH; Jeon YJ; Lee DS; Kim JH; Choi JY; Ahn BM; Kim S; Yoo HS; Kim YS; Kim NS
    Int J Oncol; 2006 Aug; 29(2):315-27. PubMed ID: 16820872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.